We came across a bullish thesis on MannKind Corporation on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on MNKD. MannKind Corporation's share was trading at $3.5000 as of February 25th. MNKD’s trailing and forward P/E were 49.91 and 34.36, respectively according to Yahoo Finance.
[caption id="attachment_557900" align="aligncenter" width="750"]MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. MNKD is emerging as a compelling...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.